Related stories
ANI Pharmaceuticals reports third-quarter adjusted EPS of $2.70
L impact | EARNINGS | Nov 05, 2026, 11:52 AM UTC
Tapestry forecasts Q2 EPS of about $3.05
M impact | EARNINGS | Nov 05, 2026, 11:51 AM UTC
ANI Pharmaceuticals forecasts FY adjusted EBITDA of $290–300 million
M impact | EARNINGS | Nov 05, 2026, 11:51 AM UTC
ANI Pharmaceuticals Reports Q3 Net Income of $35.1 Million
L impact | EARNINGS | Nov 05, 2026, 11:51 AM UTC
Tapestry Reports Revenue of $1.89 Billion, EPS of $1.76 for 3Q 2026
A 10-Q summary says Tapestry’s fiscal first-quarter 2027 net sales and earnings increased year over year, with higher Coach sales and lower Kate Spade sales.
M impact | EARNINGS | Nov 05, 2026, 11:51 AM UTC
Advanced Drainage Systems Expects Fiscal 2027 Sales of $3.30B-$3.40B
The company expects fiscal 2027 sales of $3.30 billion to $3.40 billion, versus the FactSet estimate of $3.43 billion.
M impact | EARNINGS | Nov 05, 2026, 11:51 AM UTC